Corient IA LLC Invests $383,000 in Welltower Inc. $WELL

Key Points

• Corient IA LLC acquired 2,500 shares of Welltower Inc. for approximately $383,000 during the first quarter, reflecting growing interest from institutional investors in the real estate investment trust.
• Welltower recently announced a quarterly dividend increase to $0.74 per share, with a dividend yield of 1.8%, up from the previous $0.67.
• Recent analyst ratings for Welltower show a mix of adjustments, with Wall Street Zen downgrading the stock to a "sell" while several other firms raised price targets and maintained "overweight" ratings.

Corient IA LLC acquired a new stake in shares of Welltower Inc. (NYSE:WELL - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,500 shares of the real estate investment trust's stock, valued at approximately $383,000.

Several other large investors also recently added to or reduced their stakes in the business. Raymond James Financial Inc. boosted its stake in Welltower by 0.6% during the first quarter. Raymond James Financial Inc. now owns 722,928 shares of the real estate investment trust's stock valued at $110,760,000 after buying an additional 4,331 shares during the period. Schneider Downs Wealth Management Advisors LP bought a new stake in Welltower during the first quarter valued at $239,000. Nations Financial Group Inc. IA ADV boosted its stake in Welltower by 256.0% during the first quarter. Nations Financial Group Inc. IA ADV now owns 17,424 shares of the real estate investment trust's stock valued at $2,670,000 after buying an additional 12,530 shares during the period. Ethic Inc. boosted its stake in Welltower by 21.5% during the first quarter. Ethic Inc. now owns 97,094 shares of the real estate investment trust's stock valued at $14,967,000 after buying an additional 17,177 shares during the period. Finally, Aberdeen Group plc lifted its stake in Welltower by 12.0% during the first quarter. Aberdeen Group plc now owns 1,497,471 shares of the real estate investment trust's stock worth $228,926,000 after purchasing an additional 160,264 shares during the last quarter. Institutional investors own 94.80% of the company's stock.

Welltower Trading Down 1.6%

Shares of WELL traded down $2.7420 during trading hours on Friday, hitting $164.1980. The company had a trading volume of 2,793,712 shares, compared to its average volume of 2,931,671. The firm has a market cap of $109.82 billion, a P/E ratio of 92.77, a P/E/G ratio of 1.87 and a beta of 0.93. The stock's 50 day moving average price is $159.00 and its 200 day moving average price is $152.16. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.44. Welltower Inc. has a 52-week low of $118.00 and a 52-week high of $171.09.

Welltower (NYSE:WELL - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The real estate investment trust reported $1.28 EPS for the quarter, topping the consensus estimate of $1.22 by $0.06. The firm had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.49 billion. Welltower had a return on equity of 3.38% and a net margin of 12.18%.The company's quarterly revenue was up 39.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.05 earnings per share. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. On average, research analysts predict that Welltower Inc. will post 4.88 EPS for the current year.

Welltower Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 21st. Shareholders of record on Tuesday, August 12th were given a dividend of $0.74 per share. This represents a $2.96 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend was Tuesday, August 12th. This is a positive change from Welltower's previous quarterly dividend of $0.67. Welltower's payout ratio is presently 167.23%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Morgan Stanley lifted their price target on Welltower from $155.00 to $160.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. Wells Fargo & Company lifted their price target on Welltower from $158.00 to $175.00 and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Wall Street Zen lowered Welltower from a "hold" rating to a "sell" rating in a research note on Thursday, May 8th. Evercore ISI lifted their price target on Welltower from $162.00 to $175.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 30th. Finally, Scotiabank reaffirmed an "outperform" rating on shares of Welltower in a research note on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $173.10.

Insiders Place Their Bets

In other news, Director Andrew Gundlach acquired 20,000 shares of the business's stock in a transaction on Monday, June 30th. The shares were acquired at an average cost of $151.46 per share, with a total value of $3,029,200.00. Following the transaction, the director owned 20,000 shares in the company, valued at $3,029,200. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.21% of the company's stock.

About Welltower

Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.